Evidence map›Paper›PMID 38844044›Full record

ArticleJournal of molecular biology2024

Robust Prediction of Relative Binding Energies for Protein-Protein Complex Mutations Using Free Energy Perturbation Calculations.

Jared M Sampson, Daniel A Cannon, Jianxin Duan, Jordan C K Epstein, Alina P Sergeeva, Phinikoula S Katsamba, Seetha M Mannepalli, Fabiana A Bahna, Hélène Adihou, Stéphanie M Guéret and 13 more

Abstract read
In one paragraph

Article in Journal of molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Discovery of 2H-Pyrrolo[3,4‑ACS medicinal chemistry letters · 2026
    Article
  3. MAVISp: A modular structure-based framework for protein variant effects.Protein science : a publication of the Protein Society · 2026
    Article
  4. A functional investigation of antibody Fc-FcRn variant binding guided bybioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Improving pJournal of chemical theory and computation · 2025
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Jared M SampsonSchrödinger, Inc., Life Sciences Software, New York, NY, USA.
Daniel A CannonSchrödinger, GmbH, Life Sciences Software, Mannheim, Germany.
Jianxin DuanSchrödinger, GmbH, Life Sciences Software, Mannheim, Germany.
Jordan C K EpsteinSchrödinger, Inc., Life Sciences Software, New York, NY, USA.
Alina P SergeevaColumbia University, Department of Systems Biology, New York, NY, USA.
Phinikoula S KatsambaColumbia University, Zuckerman Mind Brain Behavior Institute, New York, NY, USA.
Seetha M MannepalliColumbia University, Zuckerman Mind Brain Behavior Institute, New York, NY, USA.
Fabiana A BahnaColumbia University, Zuckerman Mind Brain Behavior Institute, New York, NY, USA.
Hélène AdihouAstraZeneca, Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, Gothenburg, Sweden; Max Planck Institute of Molecular Physiology, AstraZeneca-MPI Satellite Unit, Dortmund, Germany.
Stéphanie M GuéretAstraZeneca, Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, Gothenburg, Sweden; Max Planck Institute of Molecular Physiology, AstraZeneca-MPI Satellite Unit, Dortmund, Germany.
Ranganath GopalakrishnanAstraZeneca, Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, Gothenburg, Sweden; Max Planck Institute of Molecular Physiology, AstraZeneca-MPI Satellite Unit, Dortmund, Germany.
Stefan GeschwindnerAstraZeneca, Mechanistic and Structural Biology, Discovery Sciences, R&D, Gothenburg, Sweden.
D Gareth ReesAstraZeneca, Biologics Engineering, R&D, Cambridge, UK.
Anna SigurdardottirAstraZeneca, Biologics Engineering, R&D, Cambridge, UK.
Trevor WilkinsonAstraZeneca, Biologics Engineering, R&D, Cambridge, UK.
Roger B DoddAstraZeneca, Biologics Engineering, R&D, Cambridge, UK.
Leonardo De MariaAstraZeneca, Medicinal Chemistry, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, Gothenburg, Sweden.
Juan Carlos MobarecAstraZeneca, Mechanistic and Structural Biology, Discovery Sciences, R&D, Cambridge, UK.
Lawrence ShapiroColumbia University, Zuckerman Mind Brain Behavior Institute, New York, NY, USA; Columbia University, Department of Biochemistry and Molecular Biophysics, New York, NY, USA.
Barry HonigColumbia University, Department of Systems Biology, New York, NY, USA; Columbia University, Zuckerman Mind Brain Behavior Institute, New York, NY, USA; Columbia University, Department of Biochemistry and Molecular Biophysics, New York, NY, USA; Columbia University, Department of Medicine, New York, NY, USA.
Andrew BuchananAstraZeneca, Biologics Engineering, R&D, Cambridge, UK.
Richard A FriesnerColumbia University, Department of Chemistry, New York, NY, USA. Electronic address: raf8@columbia.edu.
Lingle WangSchrödinger, Inc., Life Sciences Software, New York, NY, USA. Electronic address: lingle.wang@schrodinger.com.

Funding

Genome-wide structure-based analysis of protein-protein interactions and networksR35GM139585 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARRY H HONIG · 2021 to 2026
$2.7M
NIGMS NIH HHS R35 GM139585
6 · The paper itself

Abstract

Computational free energy-based methods have the potential to significantly improve throughput and decrease costs of protein design efforts. Such methods must reach a high level of reliability, accuracy, and automation to be effectively deployed in practical industrial settings in a way that impacts protein design projects. Here, we present a benchmark study for the calculation of relative changes in protein-protein binding affinity for single point mutations across a variety of systems from the literature, using free energy perturbation (FEP+) calculations. We describe a method for robust treatment of alternate protonation states for titratable amino acids, which yields improved correlation with and reduced error compared to experimental binding free energies. Following careful analysis of the largest outlier cases in our dataset, we assess limitations of the default FEP+ protocols and introduce an automated script which identifies probable outlier cases that may require additional scrutiny and calculates an empirical correction for a subset of charge-related outliers. Through a series of three additional case study systems, we discuss how Protein FEP+ can be applied to real-world protein design projects, and suggest areas of further study.

Indexed as

Protein BindingProteinsThermodynamicsComputational BiologyModels, MolecularMutationPoint MutationProtein ConformationProteinsbinding affinity predictionfree energy methodsin silico mutational screeningprotein binding interface optimizationprotein-protein interactions

Identifiers

PMID38844044
PMCPMC11339910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.